INTERNATIONAL PATENT: BIOVERSYS AG FILES APPLICATION FOR "LYOPHILIZED FORMULATIONS OF RIFABUTIN"

GENEVA, Feb. 2 -- BIOVERSYS AG (Hochbergerstrasse 60c4057 Basel) filed a patent application (PCT/EP2025/071161) for "LYOPHILIZED FORMULATIONS OF RIFABUTIN" on Jul 23, 2025. With publication no. WO/2026/022215, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JAGER, Jurgen (c/o BioVersys AGHochbergerstr. 60c4057 Basel), SCHILL, Julian (c/o BioVersys AGHochbergerstr. 60c4057 Basel)

Abstract: The invention provides solutions for lyophilization, a lyophilized formulation, and a reconstituted formulation containing rifabutin a...